NEW YORK – Exuma Biotech on Tuesday said it will collaborate with Moffitt Cancer Center to advance the development its point-of-care CAR T-cell product for B-cell malignancies.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.